TY - JOUR
AU - Joy, Mark
AU - Agrawal, Utkarsh
AU - Fan, Xuejuan
AU - Robertson, Chris
AU - Anand, Sneha N.
AU - Ordóñez-Mena, Jose M.
AU - Byford, Rachel
AU - Goudie, Rosalind
AU - Jamie, Gavin
AU - Kar, Debasish
AU - Williams, John
AU - Marsden, Gemma L.
AU - Tzortziou-Brown, Victoria
AU - Sheikh, Aziz
AU - Hobbs, F.D. Richard
AU - de Lusignan, Simon
PY - 2023
DA - July
TI - Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort
JO - The Lancet Regional Health - Europe
VL - 32
DO - https://doi.org/10.1016/j.lanepe.2023.100681
AB - BackgroundThrombosis associated with thrombocytopenia was a matter of concern post first and second doses of BNT162b2 and ChAdOx1 COVID-19 vaccines. Therefore, it is important to investigate the risk of thrombocytopenic,thromboembolicand haemorrhagic events following a second dose of BNT162b2 and ChAdOx1 COVID-19 vaccines.
PB - Elsevier
UR - https://publichealthscotland.scot/id/144295
KW - Coronavirus (COVID-19)
ER